.jpg/fit-in/500x500/filters:no_upscale())
Ashwin Singhania
Partner/Principal
Ernst & Young, LLP
20+ years of experience in Life Sciences advising biopharma companies to support strategic growth. Specialized in corporate, BU, and brand growth across therapeutic areas, with emphasis on Oncology and Cardiology.
Ashwin has moderated this same panel/topic for BIO 2024 and BIO 2025.
Sessions
-
24-Jun-202624BCOncology Investment Trends: Where Is the Industry Making Its Bets?
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}